This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Young-PEARL Study - Palbociclib + Exemestane With GnRH Agonist vs. Capecitabine in Premenopausal Patients With HR+/HER2- mBC"

248 views
July 10, 2024
Comments 0
Login to view comments. Click here to Login